MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.breast.2026.104747

Медицинская библиотека · Breast (Edinburgh, Scotland) · 2026

External validation of a data-driven algorithm to identify breast cancer recurrences from administrative healthcare data.

Mancini Silvia, Giudici Fabiola, Bucchi Lauro, Biggeri Annibale, Giuliani Orietta, Baldacchini Flavia, Ravaioli Alessandra, Zamagni Federica, Toffolutti Federica, Guzzinati Stefano, Dal Maso Luigino, Falcini Fabio, Vattiato Rosa

СтатьяВалидационное исследованиеПеревод в очереди

Аннотация

INTRODUCTION

Population-based data on the incidence of breast cancer (BC) recurrence are scarce, because tracking the relevant information is resource-consuming. We report the external validation of a data-driven case-finding algorithm to identify selected treatment and procedure codes relating to BC recurrences from administrative healthcare data.

METHODS

We linked a cancer registry-based cohort of BC patients from the Emilia-Romagna (northern Italy) regional hospital discharge and outpatient care databases, and we ran the algorithm. We compared the algorithm-determined incidence and temporal pattern of recurrences during 10 years of follow-up with those obtained with a manual clinical chart review.

RESULTS

The algorithm had a 92.3% (95% confidence interval: 87.2%; 95.8%) sensitivity, a 98.0% (97.0%; 98.8%) specificity, a 88.1% (82.4%; 92.5%) positive predictive value and a 98.8% (97.9%; 99.3%) negative predictive value. The two curves of subhazard rates of total recurrences showed a good degree of overlapping and both exhibited the expected bimodal temporal pattern, with a peak between the 2nd and the 3rd year of follow-up and another between the 8th and the 9th year. The algorithm-based 10-year cumulative incidence function of recurrence was 15.8% (13.7%; 18.1%) versus 15.0% (13.0%; 17.3%). The algorithm captured with good precision the temporal pattern of recurrence by molecular profile. The design of the algorithm excluded the recurrences (11.1% of the total) detected during the first 12 months (HER2-negative BC) and 24 months (HER2-positive BC) after the diagnosis.

CONCLUSIONS

This validation study demonstrates that identifying breast cancer recurrences from administrative healthcare data is feasible and sufficiently reliable.

Для цитирования: Mancini Silvia, Giudici Fabiola, Bucchi Lauro, Biggeri Annibale, Giuliani Orietta, Baldacchini Flavia, Ravaioli Alessandra, Zamagni Federica, Toffolutti Federica, Guzzinati Stefano, Dal Maso Luigino, Falcini Fabio, Vattiato Rosa. External validation of a data-driven algorithm to identify breast cancer recurrences from administrative healthcare data.. Breast (Edinburgh, Scotland). 2026. DOI: 10.1016/j.breast.2026.104747.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.